LoginRegister
    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation OfficerBayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer
    Roche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancerRoche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial...
    USFDA completes inspection of Strides Pharmas Alathur facility with zero observationsUSFDA completes inspection of Strides Pharma's Alathur facility with zero observations
    Roche wins approval for cancer drug Kadcyla in ChinaRoche wins approval for cancer drug Kadcyla in China
    DCGI releases list of Reference Products for conduct of BE Study, detailsDCGI releases list of Reference Products for conduct of BE Study, details
    Kiran Mazumdar Shaw to be Executive Chairperson of Biocon for 5 years starting April 2020Kiran Mazumdar Shaw to be Executive Chairperson of Biocon for 5 years starting April 2020
    Patanjali group eyes to be Rs 40,000-crore company in 2020-21Patanjali group eyes to be Rs 40,000-crore company in 2020-21
    Sanofi Completes Acquisition of SynthorxSanofi Completes Acquisition of Synthorx
    Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertensionAlembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension
    Strides Pharma arm gets tentative USFDA nod for skin ointmentStrides Pharma arm gets tentative USFDA nod for skin ointment
    Syngene International Limited announces Q3 FY20 resultsSyngene International Limited announces Q3 FY20 results
    Johnson & Johnson misses revenue estimates as blockbuster drugs disappointJohnson & Johnson misses revenue estimates as blockbuster drugs disappoint
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X